Serving hundreds of leading biopharmaceutical companies globally:

Generated: July 21, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,192,756

Try a free trial See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,192,756 protect, and when does it expire?

Patent 8,192,756 protects GRALISE and is included in one NDA.

This patent has twenty-four patent family members in nine countries.

Summary for Patent: 8,192,756

Title:	Gastric retained gabapentin dosage form
Abstract:	A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
Inventor(s):	Berner; Bret (Half Moon Bay, CA), Hou; Sui Yuen Eddie (Foster City, CA), Gusler; Gloria M (Cupertino, CA)
Assignee:	Depomed, Inc. (Menlo Park, CA)
Application Number:	13/111,575
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,192,756
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 8,192,756
Patent Claim Types: see list of patent claims	Compound; Dosage form; Use;

Drugs Protected by US Patent 8,192,756

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Assertio	GRALISE	gabapentin	TABLET;ORAL	022544-001	Jan 28, 2011	BX	RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA	➤ Sign Up
Assertio	GRALISE	gabapentin	TABLET;ORAL	022544-002	Jan 28, 2011	BX	RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			TREATMENT WITH GABAPENTIN, INCLUDING TREATMENT OF NEUROPATHIC PAIN, INCLUDING NEUROPATHIC PAIN ASSOCIATED WITH POSTHERPETIC NEURALGIA	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 8,192,756

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2002348828	➤ Sign Up
Australia	2005267738	➤ Sign Up
Australia	2006332690	➤ Sign Up
Canada	2464322	➤ Sign Up
Canada	2575555	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.